WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NASDAQ : NURO) announced today that it plans to issue its 2016 first quarter financial results before the opening of the market on April 21, 2016 . The Company will host a conference call at 8:00 a.m., Eastern Time on April 21, 2016 to discuss
BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today reported continued strong media attention focusing on the company's innovative Quell ® Wearable Pain Relief Technology ™ . Highlights include: Newsweek - This FDA-approved wearable says it relieves chronic pain without any drugs
WALTHAM, Mass --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Premera Blue Cross , a leading health plan in the Pacific Northwest , will pilot the Quell ® Wearable Pain Relief device within their organization. Through this innovative collaboration, Premera will provide
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the 2016 Sidoti Emerging Growth Convention at the Marriott Marquis in New York, NY on March 31, 2016 . Dr.
The Only FDA Cleared 24/7 Wearable for Chronic Pain Relief Without a Prescription WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell ® Wearable Pain Relief Technology ™ will be featured at the Midwest Podiatry Conference to be held March 31-April 3 at the
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that Quell ® will be included in a new digital health initiative in over 500 Target ® stores nationwide beginning in April. "We are delighted that Target will include Quell in their digital health program,"
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that Quell ® was named Winner in the Wearable Tech category at the 19 th Annual SXSW Interactive Innovation Awards, held last night in Austin, TX. The Wearable Tech award honors "new hardware that revolutionizes
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) today announced that Quell ® Wearable Pain Relief Technology ™ will be featured at the SXSW Health & MedTech Expo from March 12-13 th in Austin, Texas . SXSW attendees can learn more about the latest generation of Quell
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that a major upgrade to the Quell Wearable Pain Relief technology has started shipping to consumers and healthcare providers. The latest version of the company's over-the-counter, 100% drug free chronic pain relief
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell has been selected as Best Consumer Product Winner in Digital Healthcare by Juniper Research in its annual Future Digital Awards for Technology & Innovation. Juniper's Future Digital Awards recognize
